Formalin treatment increases the stability and immunogenicity of coxsackievirus B1 VLP vaccine.
Sign Up to like & getrecommendations! Published in 2019 at "Antiviral research"
DOI: 10.1016/j.antiviral.2019.104595
Abstract: Type B Coxsackieviruses (CVBs) are a common cause of acute and chronic myocarditis, dilated cardiomyopathy and aseptic meningitis. However, no CVB-vaccines are available for human use. We have previously produced virus-like particles (VLPs) for CVB3… read more here.
Keywords: cvb1; treatment; stability immunogenicity; vaccine ... See more keywords